Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Integra Lifesciences Holdings (IART) Non Operating Income (2016 - 2025)

Integra Lifesciences Holdings' Non Operating Income history spans 17 years, with the latest figure at $581000.0 for Q4 2025.

  • For Q4 2025, Non Operating Income fell 42.19% year-over-year to $581000.0; the TTM value through Dec 2025 reached -$2.4 million, down 159.61%, while the annual FY2025 figure was -$2.4 million, 159.61% down from the prior year.
  • Non Operating Income for Q4 2025 was $581000.0 at Integra Lifesciences Holdings, up from -$842000.0 in the prior quarter.
  • Across five years, Non Operating Income topped out at $4.9 million in Q1 2021 and bottomed at -$1.9 million in Q2 2025.
  • The 5-year median for Non Operating Income is $1.4 million (2023), against an average of $1.3 million.
  • The largest annual shift saw Non Operating Income soared 1116.49% in 2021 before it crashed 235.42% in 2025.
  • A 5-year view of Non Operating Income shows it stood at $4.9 million in 2021, then decreased by 18.85% to $4.0 million in 2022, then crashed by 49.05% to $2.0 million in 2023, then plummeted by 50.07% to $1.0 million in 2024, then plummeted by 42.19% to $581000.0 in 2025.
  • Per Business Quant, the three most recent readings for IART's Non Operating Income are $581000.0 (Q4 2025), -$842000.0 (Q3 2025), and -$1.9 million (Q2 2025).